These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 8562141)

  • 21. Palliative treatment of patients with colorectal cancer.
    Glimelius B
    Scand J Surg; 2003; 92(1):74-83. PubMed ID: 12705554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Raltitrexed, a novel folate-based thymidylate synthase inhibitor, for the treatment of acute leukemia: is this drug active against acute myelogenous leukemia?
    Takemura Y; Kobayashi H; Miyachi H
    Int J Hematol; 2000 Jul; 72(1):112-4. PubMed ID: 10979221
    [No Abstract]   [Full Text] [Related]  

  • 23. 'Tomudex' (ZD1694): a novel thymidylate synthase inhibitor with clinical antitumour activity in a range of solid tumours. 'Tomudex' International Study Group.
    Cunningham D; Zalcberg J; Smith I; Gore M; Pazdur R; Burris H; Meropol NJ; Kennealey G; Seymour L
    Ann Oncol; 1996 Feb; 7(2):179-82. PubMed ID: 8777175
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Raltitrexed combined with bevacizumab in heavily pretreated metastatic colorectal cancer.
    Cheng K; Chen Y; Li LH; Liu JY
    J Cancer Res Ther; 2013; 9(4):727-9. PubMed ID: 24518728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Recent advance in chemotherapy for advanced colorectal cancer].
    Aiba K
    Gan To Kagaku Ryoho; 1996 Apr; 23(5):535-48. PubMed ID: 8678510
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Raltitrexed, a new drug for advanced colorectal cancer.
    Mead GM
    Lancet; 1996 Jun; 347(9015):1568-9. PubMed ID: 8667859
    [No Abstract]   [Full Text] [Related]  

  • 27. Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer. "Tomudex" Colorectal Cancer Study Group.
    Cunningham D; Zalcberg JR; Rath U; Oliver I; van Cutsem E; Svensson C; Seitz JF; Harper P; Kerr D; Perez-Manga G
    Ann Oncol; 1996 Nov; 7(9):961-5. PubMed ID: 9006748
    [No Abstract]   [Full Text] [Related]  

  • 28. Thymidylate synthase expression in advanced colorectal cancer predicts for response to raltitrexed.
    Farrugia DC; Ford HE; Cunningham D; Danenberg KD; Danenberg PV; Brabender J; McVicar AD; Aherne GW; Hardcastle A; McCarthy K; Jackman AL
    Clin Cancer Res; 2003 Feb; 9(2):792-801. PubMed ID: 12576452
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thymidylate synthase inhibitors in colorectal cancer.
    Cassidy J
    Semin Oncol; 2000 Oct; 27(5 Suppl 10):83-7. PubMed ID: 11049037
    [No Abstract]   [Full Text] [Related]  

  • 30. Raltitrexed: optimism and reality.
    Wilson KS; Malfair Taylor SC
    Expert Opin Drug Metab Toxicol; 2009 Nov; 5(11):1447-54. PubMed ID: 19863453
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)].
    de Gramont A; Louvet C; André T; Tournigand C; Raymond E; Molitor JL; Krulik M
    Rev Med Interne; 1997; 18 Suppl 4():372s-378s. PubMed ID: 9365715
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Colon cancer: new drug options improve on 5-FU.
    McCann J
    J Natl Cancer Inst; 1998 Jul; 90(13):963-5. PubMed ID: 9665142
    [No Abstract]   [Full Text] [Related]  

  • 33. Quality of life in advanced colorectal cancer.
    Conroy T; Guillemin F
    J Clin Oncol; 1999 May; 17(5):1644. PubMed ID: 10334556
    [No Abstract]   [Full Text] [Related]  

  • 34. Inhibition of thymidylate synthase: biochemical pharmacology of drugs with activity in colorectal cancer.
    Jackman AL
    Tumori; 1997; 83(1 Suppl):S65-6. PubMed ID: 9154072
    [No Abstract]   [Full Text] [Related]  

  • 35. [Oxaliplatin: combinations with thymidylate synthetase inhibitors: two consecutive phase II studies].
    Martoni A; Mini E; Pinto C; Gentile A; Mazzei T
    Tumori; 2001; 87(6):A25-6. PubMed ID: 11995701
    [No Abstract]   [Full Text] [Related]  

  • 36. ZD1694: A novel thymidylate synthase inhibitor with substantial activity in the treatment of patients with advanced colorectal cancer. Tomudex Colorectal Study Group.
    Zalcberg JR; Cunningham D; Van Cutsem E; Francois E; Schornagel J; Adenis A; Green M; Iveson A; Azab M; Seymour I
    J Clin Oncol; 1996 Mar; 14(3):716-21. PubMed ID: 8622016
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Single agent infusional 5-fluorouracil is not effective second-line therapy after raltitrexed (Tomudex) in advanced colorectal cancer.
    Farrugia DC; Norman AR; Cunningham D
    Eur J Cancer; 1998 Jun; 34(7):987-91. PubMed ID: 9849444
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tomudex (ZD1694): from concept to care, a programme in rational drug discovery.
    Jackman AL; Boyle FT; Harrap KR
    Invest New Drugs; 1996; 14(3):305-16. PubMed ID: 8958186
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Open, randomized, multicenter trial of raltitrexed versus fluorouracil plus high-dose leucovorin in patients with advanced colorectal cancer. Tomudex Colorectal Cancer Study Group.
    Cocconi G; Cunningham D; Van Cutsem E; Francois E; Gustavsson B; van Hazel G; Kerr D; Possinger K; Hietschold SM
    J Clin Oncol; 1998 Sep; 16(9):2943-52. PubMed ID: 9738562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Polymorphisms in the thymidylate synthase gene predict response to 5-fluorouracil therapy in colorectal cancer.
    Gibson TB
    Clin Colorectal Cancer; 2006 Jan; 5(5):321-3. PubMed ID: 16512989
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.